APOB and metabolic syndrome: The INTERHEART study, an observational study involving 52 countries spread across all continents, found that persons with history of myocardial infarction had three times the odds of having a raised ApoB/ApoA1 ratio (surrogate for atherogenic dyslipidemia) compared to persons without history of myocardial infarction [32].